(Q33475558)

27 July 2017

title

Phase I controlled trials of WR-2721 and cyclophosphamide (English)

1 reference

27 July 2017

Phase I Controlled trials of WR-2721 and cyclophosphamide (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

2 August 2023

main subject

phase I clinical trial

0 references

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

2 August 2023

author name string

J. H. Glick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

D. Glover

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

C. Weiler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

L. Norfleet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

J. Yuhas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

M. M. Kligerman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090370

2 August 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

full work available at URL

27 July 2017

https://api.elsevier.com/content/article/PII:0360301684905480?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

https://api.elsevier.com/content/article/PII:0360301684905480?httpAccept=text/plain

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

International Journal of Radiation Oncology Biology Physics

2 August 2023

published in

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

9

1 reference

27 July 2017

page(s)

1777-1780

1 reference

Phase I clinical trials of WR-2721 with alkylating agent chemotherapy

27 July 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

Sensitizers and protectors in clinical oncology

2 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

Clinical trial of the effect of S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721) (NSC 296961) on the toxicity of cyclophosphamide

2 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine

2 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide

2 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(84)90548-0

2 August 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6090370

2 August 2023

1 reference